Previous studies have described higher circulating concentrations of ACPA in RA patients positive for HLA-DRB*0104 relative to those in patients positive for HLA-DRB*0103, while the S2 and S3P risk alleles have also been reported to be associated with increased levels of ACPA [32–34]. Here, PRTN3 is linked to rheumatoid arthritis.